Drug Shortage Report for RIXUBIS
Report ID | 141947 |
Drug Identification Number | 02431947 |
Brand name | RIXUBIS |
Common or Proper name | Recombinant Coagulation Factor IX (rFIX), Nonacog gamma |
Company Name | TAKEDA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | NONACOG GAMMA |
Strength(s) | 1000UNIT |
Dosage form(s) | POWDER FOR SOLUTION KIT |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5 mL Vial |
ATC code | B02BD |
ATC description | VITAMIN K AND OTHER HEMOSTATICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2021-07-07 |
Actual start date | 2021-07-07 |
Estimated end date | 2021-08-27 |
Actual end date | 2021-08-25 |
Shortage status | Resolved |
Updated date | 2021-08-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2021-08-26 | English | Compare |
v9 | 2021-08-25 | French | Compare |
v8 | 2021-08-25 | English | Compare |
v7 | 2021-07-08 | English | Compare |
v6 | 2021-07-07 | French | Compare |
v5 | 2021-07-07 | English | Compare |
v4 | 2021-07-07 | French | Compare |
v3 | 2021-07-07 | English | Compare |
v2 | 2021-07-07 | English | Compare |
v1 | 2021-07-07 | English | Compare |
Showing 1 to 10 of 10